Literature DB >> 21368229

Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10.

Hongwei Wang1, Fengdong Cheng, Karrune Woan, Eva Sahakian, Oscar Merino, Jennifer Rock-Klotz, Ildefonso Vicente-Suarez, Javier Pinilla-Ibarz, Kenneth L Wright, Edward Seto, Kapil Bhalla, Alejandro Villagra, Eduardo M Sotomayor.   

Abstract

APCs are important in the initiation of productive Ag-specific T cell responses and the induction of T cell anergy. The inflammatory status of the APC at the time of encounter with Ag-specific T cells plays a central role in determining such divergent T cell outcomes. A better understanding of the regulation of proinflammatory and anti-inflammatory genes in its natural setting, the chromatin substrate, might provide novel insights to overcome anergic mechanisms mediated by APCs. In this study, we show for the first time, to our knowledge, that treatment of BALB/c murine macrophages with the histone deacetylase inhibitor LAQ824 induces chromatin changes at the level of the IL-10 gene promoter that lead to enhanced recruitment of the transcriptional repressors HDAC11 and PU.1. Such an effect is associated with diminished IL-10 production and induction of inflammatory cells able of priming naive Ag-specific T cells, but more importantly, capable of restoring the responsiveness of anergized Ag-specific CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21368229      PMCID: PMC3998678          DOI: 10.4049/jimmunol.1001101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 3.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

4.  Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

Authors:  K Staveley-O'Carroll; E Sotomayor; J Montgomery; I Borrello; L Hwang; S Fein; D Pardoll; H Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression.

Authors:  E M Sotomayor; I Borrello; F M Rattis; A G Cuenca; J Abrams; K Staveley-O'Carroll; H I Levitsky
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

6.  Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study.

Authors:  E Reuss; R Fimmers; A Kruger; C Becker; C Rittner; T Höhler
Journal:  Genes Immun       Date:  2002-11       Impact factor: 2.676

Review 7.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

9.  Chromatin-level regulation of the IL10 gene in T cells.

Authors:  Sin-Hyeog Im; Axel Hueber; Silvia Monticelli; Kyu-Ho Kang; Anjana Rao
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

10.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention.

Authors:  Nina J Chu; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Clin Cancer Res       Date:  2015-01-26       Impact factor: 12.531

Review 2.  Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.

Authors:  Karrune V Woan; Eva Sahakian; Eduardo M Sotomayor; Edward Seto; Alejandro Villagra
Journal:  Immunol Cell Biol       Date:  2011-11-22       Impact factor: 5.126

3.  Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer.

Authors:  Charles A Dinarello; Gianluca Fossati; Paolo Mascagni
Journal:  Mol Med       Date:  2011-05-05       Impact factor: 6.354

4.  LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in mice.

Authors:  Dapeng Wang; Cristina Iclozan; Chen Liu; Changqing Xia; Claudio Anasetti; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-12       Impact factor: 5.742

5.  Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.

Authors:  Joel A Bergman; Karrune Woan; Patricio Perez-Villarroel; Alejandro Villagra; Eduardo M Sotomayor; Alan P Kozikowski
Journal:  J Med Chem       Date:  2012-10-23       Impact factor: 7.446

6.  The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity.

Authors:  David M Woods; Karrune Woan; Fengdong Cheng; Hongwei Wang; Patricio Perez-Villarroel; Calvin Lee; Maritza Lienlaf; Peter Atadja; Edward Seto; Jeffrey Weber; Eduardo M Sotomayor; Alejandro Villagra
Journal:  Melanoma Res       Date:  2013-10       Impact factor: 3.599

Review 7.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs.

Authors:  Fengdong Cheng; Maritza Lienlaf; Hong-Wei Wang; Patricio Perez-Villarroel; Calvin Lee; Karrune Woan; Jennifer Rock-Klotz; Eva Sahakian; David Woods; Javier Pinilla-Ibarz; Jay Kalin; Jianguo Tao; Wayne Hancock; Alan Kozikowski; Edward Seto; Alejandro Villagra; Eduardo M Sotomayor
Journal:  J Immunol       Date:  2014-08-08       Impact factor: 5.422

Review 9.  The role of myeloid cells in cancer therapies.

Authors:  Camilla Engblom; Christina Pfirschke; Mikael J Pittet
Journal:  Nat Rev Cancer       Date:  2016-07       Impact factor: 60.716

10.  Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes.

Authors:  Naoko Hara; Aimon K Alkanani; Charles A Dinarello; Danny Zipris
Journal:  J Mol Med (Berl)       Date:  2013-08-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.